Inogen Inc. buy melinda
Start price
16.10.18
/
50%
€191.04
Target price
08.11.18
€225.50
Performance (%)
-28.00%
End price
08.11.18
€137.55
Summary
This prediction ended on 08.11.18 with a price of €137.55. The prediction for Inogen Inc. disappointed with a performance of -28.00%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Inogen Inc. | -2.475% | -2.475% | 79.091% | -75.858% |
iShares Core DAX® | 1.887% | 1.967% | 17.000% | 18.227% |
iShares Nasdaq 100 | 2.316% | -1.227% | 22.986% | 35.321% |
iShares Nikkei 225® | 1.134% | 0.390% | 9.520% | -0.898% |
iShares S&P 500 | 1.821% | 0.790% | 22.957% | 39.161% |
Comments by melinda for this prediction
In the thread Inogen Inc. diskutieren
SecteurEquipement, fournitures et distribution médicale Agenda 06/11 Publication de résultats
Operates as a medical technology company
Inogen, Inc . engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
Its products consists of Inogen One G4 system, Inogen One G3 system, Inogen One G2 system, and Inogen at Home.
The company was founded by Alison Perry, Alison Bauerlein, Brenton Taylor and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.
Inogen, Inc . engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
Its products consists of Inogen One G4 system, Inogen One G3 system, Inogen One G2 system, and Inogen at Home.
The company was founded by Alison Perry, Alison Bauerlein, Brenton Taylor and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.
Nombre d'employés : 770 personnes.
(Vom Mitglied beendet)